59 results
424B3
EX-23.1
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation in this Supplement No.1 filed Pursuant to Rule 424(b
424B3
RGBP
Regen BioPharma Inc
20 Nov 23
Prospectus supplement
9:38am
of each product in humans. Each clinical study is conducted under the auspices of an independent Institutional Review Board (“IRB”). The IRB will consider …
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of Regen Biopharma, Inc.:
Opinion
424B3
RGBP
Regen BioPharma Inc
2 Oct 23
Prospectus supplement
1:42pm
and may exceed the assets of the Company.
WE MAY HAVE DIFFICULTY IN ATTRACTING AND RETAINING MANAGEMENT AND OUTSIDE INDEPENDENT MEMBERS TO OUR BOARD … to serve on our board of directors. We may lose potential independent board members and management candidates to other companies that have greater
8-K
EX-10.1
rp92x9gb8wcveik4cj
18 Sep 23
Entry into a Material Definitive Agreement
4:02pm
424B3
1zjg8h
15 May 23
Prospectus supplement
10:25am